Nanomedicine, a leading MEDLINE-indexed journal, has published a special focus issue highlighting the interdisciplinary nature of this emerging field, which explores the medical application of nanotechnology to monitor, repair, and control human biological systems at the molecular level. Nanomedicine is published by Future Science Group.
"This special issue brings the different actors of nanomedicine closer together and encourages scientists to better understand the work of others who perform outside their own comfort zone," said Michael Schillmeier, who co-guest-edited the two-volume issue with Robert Luxenhofer and Matthias Barz. "With a rather unique assemblage of input and opinion from scientists, philosophers, clinicians and social scientists, it is the beginning of an experiment in itself to rethink nanomedicine in the making."
Contributing authors to the issue address the historical trajectory of the field, current debates, and future perspectives on nanomedical research. The articles position nanomedicine as not just a biological, chemical, and physical issue, but also a social issue. Of particular note, the articles bring together natural scientists, social scientists, clinicians and philosophers to both critically discuss and also engage with the creation of novel practices, concepts, methods, models and metaphors in nanomedicine. The authors also address the medical and regulatory needs of current nanomedical research and its possible future.
"Over the last decade, nanomedicine has become a field of innovative research and is now seen as having the potential to overcome many of the shortcomings of current disease treatment strategies. However, these exciting scientific advances have been accompanied by a number of issues which touch on the social, ethical and safety aspects of nanomedicine," said Jonathan Wilkinson, Commissioning Editor of Nanomedicine. "This special issue seeks to address this, bringing together carefully selected experts from around the world who discuss the past, present and future of nanomedicine from a range of perspectives. We hope that the readers of the journal find the topics and viewpoints presented in the articles as interesting and thought-provoking as we have."
Nanomedicine is a uniquely medicine-focused journal, addressing the important challenges and advances in medical nanoscale-structured material and devices, biotechnology devices and molecular machine systems and nanorobotics, delivering this essential information in concise, clear and attractive article formats. The journal is a valuable information source for all players in the field – academic, industrial and clinical researchers, pharmaceutical and biotechnology companies, regulatory authorities and others across the scientific community.
Please find the special focus issues here –
Special Focus Issue Part 1: Quo vadis nanomedicine: past, present and future of nanomedicine
Special Focus Issue Part 2: Quo vadis nanomedicine: past, present and future of nanomedicine
About Future Science Group
Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological, and scientific research. FSG's portfolio includes two imprints, Future Science and Future Medicine. Both publish eBooks and journals. In addition to this core publishing business FSG develops specialist eCommunities. Key titles and sites includes Bioanalysis Zone, Epigenomics, Nanomedicine and the award-winning Regenerative Medicine.
The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards. http://www.future-science-group.com